Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.

× No keyword cloud information.

24 in total

Review 1. Therapeutic potential of complement modulation.

Authors: Eric Wagner; Michael M Frank
Journal: Nat Rev Drug Discov Date: 2009-12-04 Impact factor: 84.694

2. Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Authors: Inge Baas; Laura Delvasto-Nuñez; Peter Ligthart; Conny Brouwer; Claudia Folman; Edimara S Reis; Daniel Ricklin; John D Lambris; Diana Wouters; Masja de Haas; Ilse Jongerius; Sacha S Zeerleder
Journal: Haematologica Date: 2020-01-31 Impact factor: 9.941

3. Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma.

Authors: Sariya Wongsaengsak; Magdalena Czader; Attaya Suvannasankha
Journal: BMJ Case Rep Date: 2018-07-10

4. Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab.

Authors: Lucy Neave; Andrew J Wilson; Maxine Lissack; Marie Scully
Journal: BMJ Case Rep Date: 2018-12-13

5. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.

Authors: Yan Li; Fiona Clow; John D Fraser; Feng Lin
Journal: J Mol Med (Berl) Date: 2018-07-31 Impact factor: 4.599

6. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena.

Authors: Alexander Röth; Christina Hock; Anna Konik; Sandra Christoph; Ulrich Dührsen
Journal: Int J Hematol Date: 2011-05-25 Impact factor: 2.490

Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.

Review 1. Therapeutic potential of complement modulation.

2. Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

3. Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma.

4. Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab.

5. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.

6. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena.

7. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.

Review 8. Paroxysmal nocturnal hemoglobinuria from bench to bedside.

9. Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report.

Review 10. Treatment of autoimmune hemolytic anemias.